Table 1:
Patient characteristics and demographic data
| GvHD (n, %) 10 patients | Control (n, %) 34 patients | P-value | ||
|---|---|---|---|---|
| Induction | Thymoglobulin | 5, 50% | 8, 23.5% | 0.13 |
| Simulect | 5, 50% | 26, 76.5% | ||
| Graft type | SB+C | 3, 30% | 19, 55.9% | 0.28 |
| L/SB/P | 0, 0% | 8, 23.5% | 0.16 | |
| MvTx | 7, 70% | 5, 14.7% | 0.002 | |
| MMvTx | 0, 0% | 2, 5.9% | 0.99 | |
| Age at transplantation | Mean (range) | 32 (0.17–53) | 21 (0.75–56) | 0.22 |
| Adults | 7, 70% | 17, 50% | 0.3 | |
| Pediatric | 3, 30% | 17, 50% | ||
| Gender | Male | 8, 80% | 20, 58.8% | 0.28 |
| Female | 2, 20% | 14, 41.2% | ||
| Race | Caucasian | 9, 90% | 24, 70.6% | 0.4 |
| African American | 1, 10% | 7, 20.6% | 0.66 | |
| Hispanic | 0, 0% | 3, 8.8% | 0.99 | |
| Indication | Short gut | 5, 50% | 20, 58.8% | 0.72 |
| Enteropathy | 2, 20% | 12, 35.3% | 0.46 | |
| Malignancy | 2, 20% | 0, 0% | 0.048 | |
| Other | 1, 10% | 2, 5.9% | 0.55 | |
| Alive | At 1 year | 7, 70% | 33, 97.1% | 0.032 |
| More than 1 year | 5, 50% | 32, 94.1% | 0.004 | |
| Retransplant | 2, 20% | 1, 2.9% | 0.125 |
C, colon; L/SB/P, liver/small bowel/pancreas; MMvTx, modified multivisceral transplant (multivisceral without liver); MvTx, multivisceral transplant; SB, small bowel.